Compare, Analyse SUVEN LIFE with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFESCIENCES   TEVA PHARMA
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
TEVA PHARMA
Dec-13
SUVEN LIFESCIENCES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3382,980-   
Low Rs1692,589-   
Sales per share (Unadj.) Rs52.11,710.2-  
Earnings per share (Unadj.) Rs6.8106.8-  
Cash flow per share (Unadj.) Rs8.6245.1-  
Dividends per share (Unadj.) Rs1.5093.52-  
Dividend yield (eoy) %0.63.4 17.6%  
Book value per share (Unadj.) Rs65.31,899.7-  
Shares outstanding (eoy) m127.28848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.91.6 298.8%   
Avg P/E ratio x37.126.1 142.4%  
P/CF ratio (eoy) x29.611.4 260.4%  
Price / Book Value ratio x3.91.5 265.0%  
Dividend payout %22.087.5 25.1%   
Avg Mkt Cap Rs m32,2722,361,010 1.4%   
No. of employees `0001.144.9 2.4%   
Total wages/salary Rs m6610-   
Avg. sales/employee Rs Th6,132.232,266.5 19.0%   
Avg. wages/employee Rs Th611.10-   
Avg. net profit/employee Rs Th803.52,015.7 39.9%   
INCOME DATA
Net Sales Rs m6,6351,450,216 0.5%  
Other income Rs m2420-   
Total revenues Rs m6,8771,450,216 0.5%   
Gross profit Rs m1,604397,143 0.4%  
Depreciation Rs m221117,222 0.2%   
Interest Rs m3828,485 0.1%   
Profit before tax Rs m1,587251,436 0.6%   
Minority Interest Rs m01,142 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-165,054 0.0%   
Tax Rs m718-3,070 -23.4%   
Profit after tax Rs m86990,594 1.0%  
Gross profit margin %24.227.4 88.3%  
Effective tax rate %45.2-1.2 -3,704.7%   
Net profit margin %13.16.2 209.8%  
BALANCE SHEET DATA
Current assets Rs m6,232979,471 0.6%   
Current liabilities Rs m1,490854,181 0.2%   
Net working cap to sales %71.58.6 827.3%  
Current ratio x4.21.1 364.7%  
Inventory Days Days8691 95.2%  
Debtors Days Days8396 86.1%  
Net fixed assets Rs m4,043473,673 0.9%   
Share capital Rs m1273,570 3.6%   
"Free" reserves Rs m8,1830-   
Net worth Rs m8,3101,610,915 0.5%   
Long term debt Rs m18741,528 0.0%   
Total assets Rs m10,3893,314,209 0.3%  
Interest coverage x43.19.8 438.6%   
Debt to equity ratio x00.5 0.5%  
Sales to assets ratio x0.60.4 146.0%   
Return on assets %8.73.6 243.0%  
Return on equity %10.55.6 186.0%  
Return on capital %19.54.9 395.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m3,8220-   
CASH FLOW
From Operations Rs m356231,089 0.2%  
From Investments Rs m-279-81,884 0.3%  
From Financial Activity Rs m-225-277,207 0.1%  
Net Cashflow Rs m-148-128,002 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.39 Rs / USD

Compare SUVEN LIFESCIENCES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare SUVEN LIFESCIENCES With: PANACEA BIOTECH  IPCA LABS  ELDER PHARMA  PIRAMAL ENTERPRISES  SHASUN PHARMA  



Today's Market

Bank Credit Growth, World Bank on Developments in India, and Top Cues in Focus Today(Pre-Open)

On Thursday, Indian share markets rose sharply during closing hours and ended on a strong note, extending gains to the fifth day.

Related Views On News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Oct 17, 2019 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS